MedicGo
Awareness of Inadvertent Use of Yellow Fever Vaccine Among Recipients of Renal Transplant.
Metadata
Journaltransplantation proceedings0.784Date
2020 Jun 03
4 months ago
Type
Journal Article
Volume
2020-Jun / 52 : 1291-1293
Author
Miranda LJC 1, Agena F 2, Sartori AMC 3, David-Neto E 2, Azevedo LS 2, Pierrotti LC 3
Affiliation
  • 2. Renal Transplantation Service, Hospital das Clinicas, University of São Paulo Medical School, São Paulo, Brazil.
  • 3. Division of Infectious Diseases, Hospital das Clinicas, University of São Paulo Medical School, São Paulo, Brazil.
Doi
PMIDMESH
Abstract
Yellow fever (YF) is a vaccine-preventable disease, but live attenuated YF vaccine (YFV) is contraindicated in immunosuppressed patients due to the risk of life-threatening YFV-associated side effects. This study aimed to evaluate 1. the knowledge of renal transplant recipients (RTRs) about the contraindication and risks of YFV; 2. the prevalence of inadvertent vaccination of RTRs against YF; and 3. the outcome of these patients. A cross-sectional telephone contact study was conducted with 200 RTRs selected from the outpatient clinic of our transplantation unit. There were 116 successful telephone contacts (58%). A total of 11 vaccinated patients were identified: 5 received YFV in the pretransplant period and 6 in the post-transplant period. All patients received the full dose of the vaccine. Among those vaccinated after transplant, only 1 reported a mild adverse event (nausea) after receiving the vaccine. All vaccinated patients who were post-transplant did not know about vaccine contraindications as a result of their clinical condition. Among the unvaccinated patients, this rate was 12.4%. YFV is the main tool for disease prevention and control as there is no specific antiviral treatment for YF. Our results confirm the evidence that transplant recipients tolerate YFV well. However, data are not strong enough to recommend this vaccine in transplant recipients. Counseling RTRs on the contraindications of YFV is important to prevent inadvertent use of this vaccine in this population.
Fav
Like
Download
Share
Export
Cite
0.8
Transplant Proctransplantation proceedings
Metadata
LocationUnited States
FromELSEVIER SCIENCE INC

No Data

© 2017 - 2020 Medicgo
Powered by some medical students